• Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Home
  • Events
  • Careers at CAPTIS
  • Log In / Sign In ▼
    • Log In with LinkedIn
    • Register w/out LinkedIn
    • Login w/out LinkedIn
    • Reset Lost Password
  • 🔒 MEMBER AREA ▼
    • View your profile
    • Edit your profile
    • Log out
       ☎ US Offices 1 (800) 445-1839 Toll Free | Europe/Int'l +41 22 518 2100
CAPTIS Executive Search
  • Home
  • You are a Business
    • Executive Search
    • Our Commitments
    • Other Services
    • Our Locations
    • About Us
    • Key Values
  • You are a Healthcare Executive
    • Dealing with CAPTIS
    • Candidate Contact Form
    • Login with LinkedIn
    • Create an Account
    • Log in (Existing Account)
    • WW Trade Shows
      • Medical & Pharmaceutical
      • Orthopedics
      • Spine
      • Cardiovascular
      • Diagnostics
      • Wound Care
      • Plastic & Aesthetic Surgery
      • Surgery
      • Trauma
      • Pediatric Care
    • Industry News
      • News
      • Wall Street Beat
      • Business/Financial News
      • Clinical Trials
      • Musculoskeletal News Roundup
      • Cardiovascular
      • M&A Activity
      • Food & Drug Administration (FDA)
      • Wound Care
      • Practice Management
  • CAPTIS Magazine
    • Healthcare News
    • @CaptisCorp Twitter Timeline
    • Healthcare Events
    • CAPTIS LinkedIn Timeline
    • Articles ➜
      • Recruiting
      • Personal Development
      • News
  • Make an Inquiry
  • Contact Us
    • General Contact Form
    • Healthcare Executive Contact
    • Apply for a position at CAPTIS
    • Call 1 800 445 1839
      (Cell/Mobile US & Canada Toll Free, or Skype)
    • Call +41 22 518 2100
      (Cell/Mobile Swiss Landline Switchboard, or Skype)
  • Search
  • Menu

Captare. Aestimare. Eligere. Succedere.

CAPTIS – Your Global Healthcare & MedTech Executive Search Provider

You are a Business

You are an Executive

Want to work at CAPTIS

Learn about our services

 

 

Executive Search
Submit an inquiry

GET HEADHUNTED!

Create and/or update

your confidential profile

 

Healthcare Executive General Information
Create an account & Add your profile

Go to our Careers page

 

 

 

 

 

CAPTIS Careers

Recent Healthcare News:

11/15/2018/by CAPTIS

SPR Therapeutics touts first CRPS treatment with Sprint PNS

SPR Therapeutics said today that it launched its FDA-cleared…
11/15/2018/by CAPTIS

Pulmonx wins Aetna coverage for Zephyr endobronchial valve

11/15/2018/by CAPTIS

Renal diagnostic dev RenalytixAI closes $29m IPO

11/15/2018/by CAPTIS

HeartFlow wins Japanese reimbursement for FFRct analysis

11/15/2018/by CAPTIS

Medtech pins tax repeal hopes on a lame duck

11/15/2018/by CAPTIS

Abbott wins CE Mark, FDA nod for DRG Invisible Trial neuromod system

11/15/2018/by CAPTIS

Report: Smiths Group looks to spin off medical biz

11/15/2018/by CAPTIS

Clinical trial project management in practice

11/15/2018/by CAPTIS

Bio-Rad, UChicago win $24m in patent infringement case

11/15/2018/by CAPTIS

Canon Medical wins FDA nod for Vantage Orion 1.5T MRI

11/15/2018/by CAPTIS

Dartmouth-Hitchcock hospitals to deploy Philips’ tele-ICU program

Philips’ eICU program combines predictive analytics, data…
11/15/2018/by CAPTIS

Lyndra touts positive results for long-acting drug-delivery tech

11/15/2018/by CAPTIS

Abbott warns against below-market mini-tender offer

11/15/2018/by CAPTIS

ivWatch inks distro deal for IV monitoring device

11/15/2018/by CAPTIS

Cerus Endovascular starts European trial of intracranial aneurysm device

11/15/2018/by CAPTIS

Neovasc dives on Q3 bottom-line miss

11/15/2018/by CAPTIS

Janssen applies for expanded approval for IMBRUVICA in Europe

11/15/2018/by CAPTIS

Seattle Genetics begins blood cancer trial with SEA-BCMA

11/14/2018/by CAPTIS

Merck’s Keytruda improves overall survival in phase 3 esophageal cancer trial

11/14/2018/by CAPTIS

AstraZeneca to sell Synagis US rights to Sobi for $1.5bn

Go to the Healthcare News

Recent news from your industry: Finance, M&A, Products, Companies and more…

Upcoming Events:

We Suggest:

Sen. Grassley grills FDA on cybersecurity improvements

0 Comments
/
11/14/2018
US Senate Committee on the Judiciary chair Sen. Chuck Grassley…
Read more
https://www.captis.com/wp-content/uploads/2018/11/fda-large-150x97-1.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 11:07:412018-11-14 12:31:09Sen. Grassley grills FDA on cybersecurity improvements

FDA warns on pain drugs for implantable pumps

0 Comments
/
11/14/2018
The FDA today warned doctors and patients about the serious complications…
Read more
https://www.captis.com/wp-content/uploads/2018/11/FDA-logo-new-150x97-1.png 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 10:31:032018-11-14 11:33:09FDA warns on pain drugs for implantable pumps

Cochlear joins $17m round for sleep apnea nueromod dev Nyxoah

0 Comments
/
11/14/2018
Cochlear Ltd. (ASX:COH) has joined a $17.1 million (EU…
Read more
https://www.captis.com/wp-content/uploads/2018/11/nyxoah-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 10:28:592018-11-14 11:33:06Cochlear joins $17m round for sleep apnea nueromod dev Nyxoah

Report: Med device recalls down in Q3

0 Comments
/
11/14/2018
Medical device recalls fell by 21% to 284 in the third quarter…
Read more
https://www.captis.com/wp-content/uploads/2018/11/StericycleExpertlogolarge-300x136.jpg 136 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 09:15:552018-11-14 10:31:26Report: Med device recalls down in Q3

Merit Medical closes $200m Cianna Medical buy

0 Comments
/
11/14/2018
Merit Medical (NSDQ:MMSI) said yesterday that it closed…
Read more
https://www.captis.com/wp-content/uploads/2018/11/merit-cianna-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 08:49:462018-11-14 10:31:24Merit Medical closes $200m Cianna Medical buy

Aegea Medical raises $17m, touts 3-year adaptive vapor ablation pivotal results

0 Comments
/
11/14/2018
Aegea Medical said this week it raised $17 million in a…
Read more
https://www.captis.com/wp-content/uploads/2018/11/aegea-medical-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 07:54:552018-11-14 09:01:35Aegea Medical raises $17m, touts 3-year adaptive vapor ablation pivotal results

Baxter expands share repurchase program to $3.4B

0 Comments
/
11/14/2018
Baxter (NYSE:BAX) said yesterday that it expanded its…
Read more
https://www.captis.com/wp-content/uploads/2018/11/baxter-large-150x97-1.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 07:53:022018-11-14 09:01:33Baxter expands share repurchase program to $3.4B

How a teenage Gary Guthart, Intuitive Surgical’s CEO, got his start at NASA

0 Comments
/
11/14/2018
Today Gary Guthart is best know as the CEO of Intuitive Surgical (NSDQ:ISRG),…
Read more
https://www.captis.com/wp-content/uploads/2018/11/intuitive-surgical-guthart-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 07:45:072018-11-14 09:01:31How a teenage Gary Guthart, Intuitive Surgical’s CEO, got his start at NASA

Varex shares fall on Q4 miss

0 Comments
/
11/14/2018
Shares in Varex Imaging (NSDQ:VREX) fell today after the…
Read more
https://www.captis.com/wp-content/uploads/2018/11/varex-imaging-updated-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 07:24:022018-11-14 08:31:35Varex shares fall on Q4 miss

Google taps ex-Geisinger CEO Feinberg to lead consolidated Google Health biz | Personnel Moves – November 14, 2018

0 Comments
/
11/14/2018
Google (NSDQ:GOOG) has picked up former Geisinger Health…
Read more
https://www.captis.com/wp-content/uploads/2018/11/google-feinberg-large-150x107.jpg 107 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 07:18:332018-11-14 08:31:32Google taps ex-Geisinger CEO Feinberg to lead consolidated Google Health biz | Personnel Moves – November 14, 2018

ResMed closes $750m MatrixCare buy

0 Comments
/
11/14/2018
ResMed (NYSE:RMD) said today that it closed the $750…
Read more
https://www.captis.com/wp-content/uploads/2018/11/matrixcare-resmed-150x97-1.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 06:11:272018-11-14 07:31:04ResMed closes $750m MatrixCare buy

Losses widen in Q3 for DJO Global

0 Comments
/
11/14/2018
DJO Global‘s third-quarter losses widened on low-single-digit…
Read more
https://www.captis.com/wp-content/uploads/2018/11/djo-global-7x41-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 05:50:182018-11-14 07:01:37Losses widen in Q3 for DJO Global

NeoChord raises $21m

0 Comments
/
11/14/2018
NeoChord has raised $20.6 million in a new round of equity financing,…
Read more
https://www.captis.com/wp-content/uploads/2018/11/neochord-large-150x97-1.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 05:43:102018-11-14 07:01:35NeoChord raises $21m

BTG invests $20m in Veran Medical’s thoracic guidance tech

0 Comments
/
11/14/2018
BTG (LON:BTG) said this week that it invested $20 million in…
Read more
https://www.captis.com/wp-content/uploads/2018/11/btg-updated-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 05:41:082018-11-14 07:01:33BTG invests $20m in Veran Medical’s thoracic guidance tech

Vapotherm prices $56m IPO

0 Comments
/
11/14/2018
Vapotherm yesterday priced an initial public offering, aiming…
Read more
https://www.captis.com/wp-content/uploads/2018/11/vapotherm-150x97-1.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 05:17:212018-11-14 06:31:48Vapotherm prices $56m IPO

Xeris Pharmaceuticals touts data for glucagon auto-injector

0 Comments
/
11/14/2018
Xeris Pharmaceuticals (NSDQ:XERS) touted data this month…
Read more
https://www.captis.com/wp-content/uploads/2018/11/xeris-pharmaceuticals-updated-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 05:02:532018-11-14 06:31:46Xeris Pharmaceuticals touts data for glucagon auto-injector

Ex-AMO chief Mazzo settle insider trading charges for $1.5m

0 Comments
/
11/14/2018
Former Advanced Medical Optics CEO James Mazzo and…
Read more
https://www.captis.com/wp-content/uploads/2018/11/advanced-medical-optics-abbott-insider-large-150x81.jpg 81 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 04:31:562018-11-14 06:01:19Ex-AMO chief Mazzo settle insider trading charges for $1.5m

Scientists engineer DNA-encoded monoclonal antibodies for Zaire Ebolavirus

0 Comments
/
11/14/2018
Study results, published online in Cell Reports, showed that…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 02:01:082018-11-14 03:01:09Scientists engineer DNA-encoded monoclonal antibodies for Zaire Ebolavirus

NextCure secures $93m funds to support clinical development of two drug candidates

0 Comments
/
11/14/2018
The financing was led by Hillhouse Capital Management and Quan…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-14 01:32:152018-11-14 02:32:16NextCure secures $93m funds to support clinical development of two drug candidates

FDA grants priority review to Tecentriq for triple-negative breast cancer

0 Comments
/
11/13/2018
The FDA designation for the Tecentriq chemo combination is for…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-11-13 23:31:062018-11-14 00:31:07FDA grants priority review to Tecentriq for triple-negative breast cancer
PreviousNext

  • Thorough Network

  • Deep Knowledge

  • Comprehensive Process

  • Ethical Approach

  • Confidentiality

  • Assessment Capacity

99%

Percentage of successful project completion

85%

Of placed executives remain with the client company 3 or more years

  • Share on Facebook
  • Share on Twitter
  • Share on Google+
  • Share on Pinterest
  • Share on Linkedin
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

News from Twitter

Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

Cancer is not a ‘one size fits all,’ nor is the way we treat it. We are working to better understand the different ways a cancer can mutate so we can discover new approaches to treat some of the most difficult-to-treat types of the disease. #ReimagineMedicine #ESMO18 pic.twitter.com/41QL…

reply retweet favorite
6:56 pm · 10/24/2018 ·
Retweeted by CAPTIS
Twitter
Epic CV
Epic CV
@Epic_CV

Read carefully employer's directions on how to apply. #resume #resumetips

reply retweet favorite
7:47 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
World Spine Care
World Spine Care
@WorldSpineCare

Here are 5 Tips to Avoid Back Pain from #WorldSpineDay. #Exercise #Posture #Stress #HealthyEating #Strength pic.twitter.com/AT1D…

reply retweet favorite
7:46 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Neurochecklists
Neurochecklists
@neurochecklists

Large-vessel giant cell arteritis: diagnosis, monitoring and management | Rheumatology | Oxford Academic academic.oup.com/rhe…

reply retweet favorite
7:40 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Stryker Endoscopy
Stryker Endoscopy
@StrykerEndo

Scientists have made an unexpected discovery while investigating the triggering factors of #ColonCancer: Cell stress in combination with an altered microbiota in the colon drives tumor growth. Learn more: ow.ly/JxtK30meLTY pic.twitter.com/U51Q…

reply retweet favorite
7:39 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Implantech
Implantech
@Implantech

If you are in Dallas attending the AAFPRS 12th International Symposium of Facial Plastic Surgery don’t miss out on this Breakfast Symposium tomorrow morning with Dr. William Binder that is sponsored by Implantech! #implantech #superiorpatientaesthetics #implantechrewards #aafprs pic.twitter.com/HCzK…

reply retweet favorite
7:38 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
AmerColl Cardiology
AmerColl Cardiology
@ACCinTouch

Less than one month left to submit your science for #ACC19! Abstract & case submissions are due Oct. 16. Learn more: ow.ly/4nyf30lYZxh pic.twitter.com/Mnwv…

reply retweet favorite
4:46 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

With #CARTcell therapy, an inactive virus programs T cells with new genetic information to help recognize specific antigens found on normal cells and certain blood cancer cells. As the CAR-T cells multiply, new copies also gain this ability. #CARTCellStory pic.twitter.com/Xuoh…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Make plans to visit the Integra LifeSciences Booth# 919 during Plastic Surgery The Meeting September 28th - October 1st. #Integra_LifeSciences #DurableIsBeautiful #PSTM18 #ASPS #PlasticSurgery pic.twitter.com/8QGv…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Fundamental Surgery
Fundamental Surgery
@FundamentalSurg

We are live at #NASS2018 stand 2649. Get hands-on with the world's leading surgical #simulator in #VR with #haptics and experience the future of surgical training. #wearefundamental fundamentalsurgery.c… pic.twitter.com/NgzA…

reply retweet favorite
4:41 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
K2M, Inc. Jobs
K2M, Inc. Jobs
@K2MIncJobs

Congratulations to Lane Major for his recent promotion to Chief Operating Officer @K2MInc! Read more: bit.ly/LaneMajor pic.twitter.com/iDXk…

reply retweet favorite
12:45 pm · 03/31/2018 ·
Retweeted by CAPTIS
Twitter
TRX Orthopedics
TRX Orthopedics
@TRXOrtho

Great things happening at Tissue Regenix! Plan to visit our booth at the AAOS meeting in New Orleans, under the CellRight Technologies banner #5413. @AAOS1

reply retweet favorite
8:34 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Corin Group
Corin Group
@corintechnology

All evaluation cases for the new Corin Dual Mobility option for the Trinity Acetabular cup system have now been completed and we're looking forward to the full launch. Click lnkd.in/g8ariEY for details #orthopaedics #technology #totalhip #uniquehip pic.twitter.com/SPsy…

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Omar Ishrak
Omar Ishrak
@MedtronicCEO

Thank you to our @Medtronic employees around the globe! Q3 saw strong, balanced results, with diversified performance in all groups and regions. #MDTEarnings

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Cardiovascular News
Cardiovascular News
@Cardiovasc_bio

#cardiovascular news CorFlow Presents Fundamental New Insights into the Coronary Microcirculation at ACC - CorFlow Therapeutics AG corflowtherapeutics.… today announced that the company will present fundamental new insights into the coronary microci... ow.ly/OlaG50gAElO

reply retweet favorite
8:32 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Welcome Sravan Emany, our new vice president, treasurer and head of investor relations. investor.integralife… pic.twitter.com/wzt5…

reply retweet favorite
8:31 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
José Luis Maçãs
José Luis Maçãs
@zeluismacas

Read in this edition all about Novartis Oncology’s ground-breaking CAR-T therapy; how SwissMedic is leading the world in terms of regulatory innovation; the story of Actelion’s acquisition by J&J and the subsequent emergence of a new entity – Idorsia. pharmaboardroom.com/…

reply retweet favorite
11:29 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
SOFCOT
SOFCOT
@sofcot_ortho

Thème du congrès SOFCOT 2018 : "La Décision Médicale" pic.twitter.com/hJT5…

reply retweet favorite
11:25 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
EUROSPINE
EUROSPINE
@EUROSPINESoc

Exactly 3 weeks left to submit your abstract for #EUROSPINE2018 - #deadline 1 March 2018 #research #spine #SpineResearch #spineSurgery #SpinalDisorder #ScientificPaper #BasicScience #ClinicalResearch #PublishResearch @EurSpineJournal buff.ly/2ExMQ7e pic.twitter.com/Fx2Q…

reply retweet favorite
11:25 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
Olea Medical
Olea Medical
@OleaMedical

Throughout the week, we are in #Bruges alongside Prof. Jan Casselman for an #Erasmus course program on #ENT imaging, held at the Oud Sint-Jan congress centre. The training of around 170 radiologists is based on images from our post-processing solution Olea Sphere®V3.0. #MRI pic.twitter.com/KSUU…

reply retweet favorite
11:24 am · 02/10/2018 ·
Retweeted by CAPTIS
Follow @CaptisCorp

Follow CAPTIS



CAPTIS
Followon TwitterSubscribeto RSS Feed

We Recommend

Our very best and up-to-date selection of healthcare Industries' News (Products, Markets, Companies, R&D, Technology, Opportunities, Investment & Finance...).
Read at Healthcare News

CAPTIS Newsletter

Call CAPTIS

United States Offices
1 (800) 445-1839

(United States & Canada Toll Free)

Europe & International
+41 22 518 2100

© CAPTIS - Executive Search - 2017 - copyright@captis.com
  • Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Events
  • For Healthcare Executives
  • Legal & Privacy Notes, GDPR & Cookies Policy
  • Client Area
X
Thank you for visiting our new website! Help us improve, let us know your feedback (Anonymous 2 min survey)
Survey
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK, got itCookies Policy
Scroll to top